Arecont Vision SurroundVideo Omni G3 Named 2017 Campus Safety BEST Winner

SurroundVideo Omni G3 Campus Safety BEST Winner

SurroundVideo Omni G3 Wins Campus Safety BEST Award

Arecont Vision SurroundVideo Omni G3 omnidirectional surveillance camera wins Campus Safety award for innovative products.

The SurroundVideo Omni G3 is the easiest multi-sensor omnidirectional camera in the industry to install, setup, and operate.”

— Brad Donaldson, VP Product Development, Arecont Vision

LOS ANGELES, CALIFORNIA, UNITED STATES, October 18, 2017 /EINPresswire.com/ — Arecont Vision®, the industry leader in IP-based megapixel camera technology, announces that the innovative SurroundVideo® Omni G3 surveillance camera has won a 2017 Campus Safety BEST Award. This is the latest award for the omnidirectional multi-megapixel Omni G3, first unveiled in 2016.

Campus Safety Magazine, honoring superior products and services for hospital, school, and university protection professionals, has announced the winners of the 2017 Campus Safety BEST Awards, including SurroundVideo Omni G3. Winning entries recognizing superlative security, law enforcement, emergency management, and safety solutions for K-12 institutions, universities, and healthcare organizations were awarded.

“Campus Safety Magazine takes pride in focusing on content that helps protection professionals in the healthcare and education markets keep their students, teachers, patients, visitors, and campuses safe and secure,” said Robin Hattersley Gray, executive editor of Campus Safety.

SurroundVideo Omni G3 is the surveillance industry’s first multi-sensor, adjustable view camera with no-touch, remote setup. This capability ensures easy and rapid installation. The multi-sensor surveillance camera market was created by Arecont Vision in 2006 with the introduction of the first SurroundVideo 180o and 360o panoramic models, followed in 2014 by Omni G1. The SurroundVideo Omni G2 with remote focus was added in 2015. Both the Omni G1 and G2 are industry-award winners in their own right, and continue to be offered alongside the new Omni G3. The three cameras are able to address any market requirement with a range of features and competitive price points.

A single high-definition SurroundVideo camera replaces multiple pan-tilt-zoom or fixed-view single-sensor cameras for a wide range of campus safety requirements, while providing non-stop entire-scene coverage and video streaming. SurroundVideo delivers enhanced high-definition video and improved situational awareness indoors and out. Omni G3 brings remote setup to simplify and speed the installation process while enabling customers to easily change their area of coverage. For example, a stadium may wish for a different view for a sports events versus a concert, and Omni G3 can be remotely adjusted, including use of several pre-set and customer-set coverage options.

SurroundVideo Omni G3 now adds the Campus Safety BEST Award to its growing list of honors. Omni G3 received a New Product of the Year Award at ASIS 2017 in Dallas, TX. The camera has also recently been named a finalist in the ongoing American Security Today ASTORS Homeland Security Awards competition.

All entries in the Campus Safety competition were judged on all aspects involved such as innovation, functionality, and benefits to the installer.

Learn more about the SurroundVideo Omni series here: http://tinyurl.com/y72dyba3

Jeff Whitney
Arecont Vision
818.937.0477
email us here


Source: EIN Presswire

PCIHIPAA Launches OfficeSafe ID™ In Response to The Equifax Breach

PCIHIPAA responds to the Equifax breach by providing ID restoration services to all of its customers, employees, and their families.

SANTA MONICA, CA, UNITED STATES, October 18, 2017 /EINPresswire.com/ — Equifax, one of the nation’s three credit reporting agencies, announced on September 7th that it was the victim of a major hack, exposing the personal information of 143 million U.S. consumers. According to the company, thieves took names, Social Security numbers, birthdates, and addresses. A lesser quantity, but still significant amount, of driver’s license numbers were also stolen. It has been reported that stolen credit card numbers were also part of the breach.

Victims of identity theft often spend laborious and painstaking hours in an attempt to restore their identities. In response to the Equifax breach, PCIHIPAA has partnered with a leading credit monitoring and restoration company to launch OfficeSafe ID™. Beginning today, all of PCIHIPAA’s medical and dental providers, along with their spouses, partners, children (under the age of 25), and parents will receive OfficeSafe ID™ at no additional cost. It will become part of their HIPAA compliance and data breach program with the company. PCIHIPAA is also adding its employees to the new program.

“None of us fully understand the downstream implications of the Equifax breach,” says Jeff Broudy, CEO of PCIHIPAA. Broudy adds, “PCIHIPAA has decided to act proactively by protecting our clients, their families, and all of our employees from the potential consequences. I’ve had my ID compromised and it’s a nightmare to fix. Today, our clients and employees can sleep easier; and that’s a good thing.”

Recently, PCIHIPAA was selected as one of the Top 10 Healthcare Compliance Providers of 2017 by Healthcare Tech Outlook Magazine. Their OfficeSafe Compliance Program is now used by thousands of medical and dental practices nationwide to mitigate the risks associated with HIPAA compliance and patient data protection.

###

About PCIHIPAA
PCIHIPAA is an industry leader in PCI and HIPAA compliance by providing turn-key, convenient solutions for its clients. Their OfficeSafe™ compliance program is now used by thousands of healthcare professionals nationwide. PCIHIPAA offers a complimentary HIPAA risk assessment at www.pcihipaa.com and helps practices implement regulatory safeguards easily and affordably. Learn more at OfficeSafe.com and PCIHIPAA.com.

Jeff Broudy
PCIHIPAA
8185198597
email us here


Source: EIN Presswire

nipsNY – NON-INVASIVE PLASTIC SURGERY – ON DEMAND

nipsNY – NON-INVASIVE PLASTIC SURGERY – ON DEMAND

nipsNY, an on-demand plastic surgery service is now your go-to for all non-invasive procedures for the face, hands and body.

Each person’s face and body has natural curves and contours, which may be improved upon. Yet, everything needs to be artfully achieved, leaving a completely natural appearance.”

— John A Perrotti, MD

NEW YORK, NY, USA, October 18, 2017 /EINPresswire.com/ — nipsNY, an on-demand plastic surgery service is now your go-to for all non-invasive procedures for the face, hands and body. Founded by NYC Top Doc, John A. Perrotti, MD, nipsNY accepts same day appointments, including home and hotel visits, as well as online eConsults.

nipsNY offers non-invasive procedures for the face and body, including fillers, toxins and liposuction – for both men and women – and minimally invasive approaches to the face and body, performed with local anesthesia.

XEOMIN® – the latest option – proven to reduce frown lines;
RADIESSE® – wrinkle filler used to plump the skin – adds volume and stimulates natural collagen. Also used for Hand Rejuvenation to immediately restore volume loss;
BELOTERO® – to temporarily smooth out and fill in nasolabial folds and lines and wrinkles;
KYBELLA® – the only injectable treatment approved by the FDA for fat reduction below the chin;
SMART LIPO® – the leader in laser-assisted lipo under local anesthesia;
SPOT LIPO – liposuction targeted to specific areas such as neck, belly and thighs, under local anesthesia.

nipsNY also offers minimally invasive procedures for facelift, necklift, tummy tuck and breast surgery, often with local anesthesia.

Special nipsNY treatments for men target face, neck, chin, love-handles, and man-boobs.

About John A. Perrotti, MD
Dr. Perrotti is a board-certified plastic surgeon with a boutique practice in New York City’s upper east side. After general surgery training in New York and plastic surgery training at the Cleveland Clinic, Dr. Perrotti completed a cosmetic surgery fellowship in Miami. He has served as Program Director of the Aesthetic Plastic Surgery fellowship at Manhattan Eye, Ear & Throat Hospital. He is Assistant Clinical Professor of Surgery at New York Medical College and has numerous publications and presentations in plastic surgery.

Dr. Perrotti is listed in Top Doctors – New York and featured in Best Beauty Docs, New York Magazine. Dr. Perrotti is one of New York City’s most respected plastic surgeons, with extensive training and over 17 years experience in surgical and non-invasive techniques.

Jennifer Paquette
John A Perrotti, MD
212-861-6363
email us here


Source: EIN Presswire

Gary Taffet Explains the Importance of Fire Insurance

NEW YORK, NEW YORK, UNITED STATES, October 18, 2017 /EINPresswire.com/ — As Gary Taffet of Reliance Insurance explains; an increasing number of business owners are learning how important it is to carry fire insurance on their property. If you run a business that owns one or more properties, it’s essential that you have coverage to protect yourself against potential damage caused by fire. Fire is a significant cause of property damage, to the tune of billions of dollars each year. Unsurprisingly, a fire can devastate a small business. Heat, smoke, and flames can all damage buildings and its contents. The materials used to put out the fire, such as water and foam, can cause further damage.
If you don’t have fire insurance, you will have to pay for reconstruction or repairs out of pocket. You may even have to reimburse the fire department if they charge for their services in your area. If you don’t have the funds to cover these expenses, your company may be forced to cease operations. You can avoid this scenario by purchasing adequate fire insurance now. Luckily, fire insurance plans are widely available, and most insurance companies that provide business insurance offer this type of coverage.

The Dangers of Underinsuring

If you’re like many business owners, you probably worry that insurance premiums are too high. You may have even entertained the thought that you could save money by insuring your property for less than its value. However, if you speak to Gary Taffet, he will explain why this is not a smart decision. For one thing, the policy won’t cover the entire cost of replacing or repairing a building or property destroyed by fire or another peril. Also, most policies contain a clause imposing a penalty if you hold less than a minimum limit of insurance relative to your property value when the loss takes place. You can avoid these issues by insuring your property for its entire value, hiring an appraiser to reassess your property’s value each year, and not buying insurance based on estimates provided by unreliable sources.

Excluded Property

Be aware that most property policies contain limitations and exclusions that apply to specific types of property. For instance, most policies exclude damage or loss to building foundations, land, and money. Some provide only a small amount of coverage for jewelry, outdoor plants, and important papers. Property policies also exclude certain types of damage, such as electrical disturbances that damage computers or data, or damage to refrigeration equipment caused by mechanical trouble, for example. You may be able to cover these perils under a separate addendum attached to the policy.

Business Income Coverage

If your property sustains severe damage, you may not have any choice other than to reduce or shut down your operations. A partial or full shutdown can cause you to incur extra expenses or lose income. Primary fire insurance will not cover income loss or additional costs. Protect your business and yourself by purchasing coverage for these possibilities.

Contact Reliance Insurance Group for Coverage
As a leading independent insurance brokerage firm, Reliance Insurance Group provides services to a variety of individuals, public entities, and business organizations. Our team of professionals, led by Gary Taffet, is committed to offering affordable and effective solutions for your unique insurance needs. For all the benefits of working with knowledgeable experts and real people who care about your success, contact Reliance Insurance Group today.

Gary Taffet
Reliance Insurance Group
732-602-0010
email us here


Source: EIN Presswire

Lutein & Zeaxanthin Supplementation for Macular Degeneration Could Lead to Significant Health Care Savings

Macular degeneration risk is reduced by lutein and zeaxanthin supplementation

Lutein helps with eye health

Eye health nutrients lutein, saffron, resveratrol and vitamins help maintain eye health

Lutein and zeaxanthin in synergy with saffron, resveratrol and vitamins helps maintain eye health

Effectiveness and safety of Saffron 2020 are established through recognized scientific and GMP procedures.”

— Dr. Piraee

MONTREAL, QUEBEC, CANADA, October 18, 2017 /EINPresswire.com/ — Age-related macular degeneration (AMD) is the number one cause of vision loss in adults over 50 in North America. It is a progressive disease that causes damage to the retina and impairs the ability to see objects straight ahead. A new study from Frost & Sullivan concluded that $7.3 billion dollars could be saved in Europe by using the combination of lutein and zeaxanthin in eye health supplements for age-related macular degeneration (AMD).

In North America, the cost of age-related macular degeneration is equally staggering and growing every year. It is estimated that 20 million adults will be affected with macular degeneration by 2020. Another study by Frost & Sullivan in 2013 concluded that $7.4 billion could be saved in the US between 2013 and 2020, if older adults at risk of developing AMD consume vision supplements containing lutein and zeaxanthin.

Increased use of computers is negatively affecting our eyesight:
A study recently concluded that North Americans sit in front of one or many electronic screens for more than 5 hours per day. This prolonged and daily exposure to blue light is playing havoc with our vision. Lutein and zeaxanthin act like sunscreen protecting our retina against oxidative damage by filtering out the excess blue light.

Are you getting enough lutein and zeaxanthin?
The human body does not naturally produce lutein or zeaxanthin so we must get it from the food we eat or by the daily use of eye supplements containing these two natural carotenoids. It is estimated that the average daily intake of lutein & zeaxanthin in the U.S. is ~2 mg, which is far below that shown to reduce the risk of age-related vision changes.

Rich dietary sources of lutein & zeaxanthin are leafy green vegetables such as kale and spinach, peas, summer squash and Brussels sprouts. Taking a good quality daily supplement is an easy way to ensure you are getting the recommended daily dose of these two important eye health nutrients.

While it is important to save on the future cost of health care system, it is more important to preserve your vision! The cost of losing one’s eyesight, independence and sense of control is incalculable. Of all the senses, losing one’s eyesight is often the most feared and has been shown to lead to increased social isolation and depression.

Saffron 2020 eye supplement provides high quality lutein & zeaxanthin:
Saffron 2020 contains lutein & zeaxanthin in addition to saffron and other eye health nutrients. It is formulated as a daily vision supplement for anyone concerned about maintaining eye health, including those affected by macular degeneration. Saffron 2020 is formulated based on more than 20 years of accumulated research on the role of nutrients for eye health. This saffron-containing eye supplement has improved the quality of life for many people affected by age-related eye health changes.

For more information or to order Saffron 2020 visit Persavita.com or call 1800.430.1422

About Persavita:
Persavita harnesses the power of super-spice saffron to create nutritional supplements for the aging population. The company’s flagship product is Saffron 2020, which is approved by Health Canada to help support and maintain eye health in age-related macular degeneration. Effectiveness and safety of Saffron 2020 are established through recognized scientific and GMP procedures.

Kathy Ware
Groupe Persavita Inc
1.800.430.1422
email us here

Lutein containing eye health supplement, Saffron 2020, has changed quality of life for many people affected by macular degeneration.


Source: EIN Presswire

Majority of Local Jurisdictions Need Improvement to Protect Communities from Mosquito-Borne Diseases, According to Study

Study by NACCHO Indicates Sustained Federal Funding Is Critical to Protect the Public From Mosquito-Borne Diseases

WASHINGTON, DC, UNITED STATES, October 18, 2017 /EINPresswire.com/ — A newly released study of local jurisdictions developed by the National Association of County and City Health Officials (NACCHO), in partnership with the Centers for Disease Control and Prevention (CDC), revealed local jurisdictions have room to improve their mosquito-control efforts, and continued federal funding to support them is needed more than ever to safeguard the nation’s health. Congress has proposed eliminating the Prevention and Public Health Fund (PPHF), which provides funding to local jurisdictions through the CDC.

The assessment, Mosquito Control Capabilities in the U.S., was developed and distributed as an electronic survey to assess mosquito surveillance and control capacity among the nearly 2,000 local vector-control programs nationwide. It showed:

• Based on the standards for competency developed and promoted by the CDC and the American Mosquito Control Association, 84% of respondents are in need of improvement in at least one core competency area.

• Mosquito surveillance and control is not performed uniformly across the U.S. For example, the local vector control organizations assessed comprise local health departments (53%), mosquito control districts (20%), and other departments (27%) (e.g., streets and sanitation, public works, environmental health services, tribal networks, utilities, parish police juries, parks and recreation).

• The top three areas for improving mosquito surveillance and control programs in the U.S. are: (1) pesticide resistance testing, (2) treating for mosquitoes based on surveillance data, and (3) routine mosquito surveillance and species identification.

“Local health departments, working in concert with their sister agencies and partners, are the frontline defense against disease in our communities. Just in the past week, a new locally transmitted case of Zika, which is spread by mosquitos, was detected in Miami. The highly trained professionals at local health departments are ‘the boots on the ground’ protecting us from mosquito-borne disease outbreaks,” said NACCHO Executive Director and Chief of Government Affairs Laura Hanen, MPP. “But if Congress eliminates the PPHF and fails to continue to allocate vital funding to support these professionals, they will leave the American public vulnerable.”

Mosquito-borne diseases, such as West Nile virus and Zika, are an ongoing public health concern in the United States. However, there is a cyclical pattern of prioritizing mosquito control capabilities. First, a newly emerging or re-emerging mosquito-borne disease outbreak triggers a pandemic or epidemic response in which municipalities, states, and countries request resources to support and improve local mosquito control. As a result, local capacity increases as staff are hired, training expanded, diagnostic tests are developed, vaccine therapies are pursued, partnerships are established, and the threat is faced head-on. But when the seasons change, mosquito populations decrease, the sense of urgency fades, and the perceived threat lessens. Consequently, funding and resources dwindle or are withdrawn. Local vector control programs are left understaffed, undertrained, and underfunded, and the public is left vulnerable to the next impending mosquito-borne disease threat.

NACCHO’s President Umair A. Shah, MD, MPH and his staff at Harris County Public Health (HCPH), which serves Houston, are now closely monitoring the mosquito population that soared in the aftermath of Hurricane Harvey. “I can’t overstate the need for continued funding and resources for local health departments, so they can protect their communities from mosquito-borne diseases. From mosquito-control programs and mosquito bite prevention education to disease surveillance, health departments have a responsibility to protect the health and well-being of their communities. Our residents are fortunate, because Harris County has local resources to support a robust vector control program. What the joint NACCHO and CDC survey has brought to light is that many of our local health departments are not so fortunate and federal support for these activities is paramount. Lives depend upon it and the health outcomes from mosquito-borne diseases, such as Zika, can be lifelong.”

# # #

About NACCHO
The National Association of County and City Health Officials (NACCHO) represents the nation's nearly 3,000 local governmental health departments. These city, county, metropolitan, district, and tribal departments work every day to protect and promote health and well-being for all people in their communities. For more information about NACCHO, please visit www.naccho.org.

Theresa Spinner
National Association of County and City Health Officials
2027835551
email us here


Source: EIN Presswire

Herbal Medicine Global Market Segmentation, Major Players, Applications and Analysis 2022

Herbal Medicine Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022

PUNE, INDIA, October 18, 2017 /EINPresswire.com/ —

Summary

WiseGuyReports.com adds “Herbal Medicine Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022” reports to its database.

Herbal medicine–also called botanical medicine or phytomedicine refers to using a plant's seeds, berries, roots, leaves, bark, or flowers for medicinal purposes. Herbalism has a long tradition of use outside of conventional medicine. It is becoming more mainstream as improvements in analysis and quality control along with advances in clinical research show the value of herbal medicine in the treating and preventing disease.

Global and Regional Herbal Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Tsumura
Schwabe
Madaus
Weleda
Blackmores
Arkopharma
SIDO MUNCUL
Arizona Natural
Dabur
Herbal Africa
Nature's Answer
Bio-Botanica
Potter's
Zand
Nature Herbs
Imperial Ginseng
Yunnan Baiyao
Tongrentang
TASLY
Zhongxin
Kunming Pharma
Sanjiu
JZJT
Guangzhou Pharma
Taiji
Haiyao

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2315483-global-and-regional-herbal-medicine-market-research-report-2017

Market Segment as follows:
By Region
Asia-Pacific
North America
Europe
South America
Middle East & Africa

By Type
Medicine Function
Medicinal part
Active Ingredient

By Application
Western Herbalism
Traditional Chinese Medicine
Others

At any Query @ https://www.wiseguyreports.com/enquiry/2315483-global-and-regional-herbal-medicine-market-research-report-2017

Table of Contents

1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Medicine Function
1.1.2.2 Medicinal part
1.1.2.3 Active Ingredient
1.1.3 Market by Application
1.1.3.1 Western Herbalism
1.1.3.2 Traditional Chinese Medicine
1.1.3.3 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 Market by Region
1.2.2.1 Asia-Pacific
1.2.2.2 North America
1.2.2.3 Europe
1.2.2.4 South America
1.2.2.5 Middle East & Africa

….

6 Key Manufacturers
6.1 Tsumura
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Schwabe
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Madaus
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Weleda
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Blackmores
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Arkopharma
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 SIDO MUNCUL
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Arizona Natural
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Dabur
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Herbal Africa
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Nature's Answer
6.12 Bio-Botanica
6.13 Potter's
6.14 Zand
6.15 Nature Herbs
6.16 Imperial Ginseng
6.17 Yunnan Baiyao
6.18 Tongrentang
6.19 TASLY
6.20 Zhongxin
6.21 Kunming Pharma
6.22 Sanjiu
6.23 JZJT
6.24 Guangzhou Pharma
6.25 Taiji
6.26 Haiyao

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2315483

Continued….

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

New Location of Exeter Orthodontics Offers Braces in Lansdale

affordable braces lansdale pa

Exeter Orthodontics has recently opened its eighth location in Eastern Pennsylvania.

Whether patients would like traditional braces or Invisalign aligners, they can find both at one low cost.”

— Dr. John Pardini

LANSDALE, PENNSYLVANIA, UNITED STATES, October 18, 2017 /EINPresswire.com/ — Exeter Orthodontics, which offers high-quality, low-priced orthodontic care across Eastern Pennsylvania, recently opened its newest location in Lansdale. The Lansdale office marks the eighth location of the orthodontist practice.

Now, patients in Hatfield, Horsham, Montgomeryville, and Willow Grove can find affordable braces in Lansdale. Braces from Exeter Orthodontics cost only $3,995 and include x-rays, adjustments, retainers, and repairs.

In addition to braces, Exeter Orthodontics also offers Invisalign® aligners in Lansdale. Like traditional braces, Invisalign aligners cost only $3,995.

“Whether patients would like traditional braces or Invisalign aligners, they can find both at one low cost,” says Dr. John Pardini, orthodontist in Lansdale.

Lansdale area residents are encouraged to request an appointment with Exeter Orthodontics today: http://www.exeterorthodontics.com/request-appointment/.

About Exeter Orthodontics: For several years, Exeter Orthodontics, a Pennsylvania-based orthodontic practice, has offered area patients braces and Invisalign treatments for as low as $3,995. Its team of orthodontists remains dedicated to providing high quality care at an affordable price. Learn more at http://www.exeterorthodontics.com/.

Meredith Souder-Liss
Exeter Orthodontics
610-401-0559
email us here

Exeter Orthodontics: Affordable Braces and Invisalign Aligners in Eastern Pennsylvania


Source: EIN Presswire

Antimalarial Drug Market 2017 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2022

Antimalarial Drug Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, October 18, 2017 /EINPresswire.com/ — Antimalarial Drug Market 2017

Wiseguyreports.Com adds “Antimalarial Drug Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

This report provides in depth study of “Antimalarial Drug Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Antimalarial Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Antimalarial Drug market, analyzes and researches the Antimalarial Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia.

This report focuses on the top players in global market, like 
Pfizer 
GlaxoSmithKline 
Ranbaxy Laboratories 
Ipca Laboratories Ltd 
Zydus Cadila 
Merck KGaA 
Novartis AG 
Alvizia Health Care 
Bayer 
Roche

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1274061-global-antimalarial-drug-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers 
United States 
EU 
Japan 
China 
India 
Southeast Asia

Market segment by Type, the product can be split into 
Plasmodium Falciparum 
Plasmodium Vivax 
Plasmodium Malariae 
Plasmodium Ovale

Market segment by Application, Antimalarial Drug can be split into 
Hospital Pharmacy 
Retail Pharmacy 
E-Commerce 
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/1274061-global-antimalarial-drug-market-size-status-and-forecast-2022

Major Key Points in Table of Content:

Global Antimalarial Drug Market Size, Status and Forecast 2022 
1 Industry Overview of Antimalarial Drug 
1.1 Antimalarial Drug Market Overview 
1.1.1 Antimalarial Drug Product Scope 
1.1.2 Market Status and Outlook 
1.2 Global Antimalarial Drug Market Size and Analysis by Regions 
1.2.1 United States 
1.2.2 EU 
1.2.3 Japan 
1.2.4 China 
1.2.5 India 
1.2.6 Southeast Asia 
1.3 Antimalarial Drug Market by Type 
1.3.1 Plasmodium Falciparum 
1.3.2 Plasmodium Vivax 
1.3.3 Plasmodium Malariae 
1.3.4 Plasmodium Ovale 
1.4 Antimalarial Drug Market by End Users/Application 
1.4.1 Hospital Pharmacy 
1.4.2 Retail Pharmacy 
1.4.3 E-Commerce 
1.4.4 Others

2 Global Antimalarial Drug Competition Analysis by Players 
2.1 Antimalarial Drug Market Size (Value) by Players (2016 and 2017) 
2.2 Competitive Status and Trend 
2.2.1 Market Concentration Rate 
2.2.2 Product/Service Differences 
2.2.3 New Entrants 
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles 
3.1 Pfizer 
3.1.1 Company Profile 
3.1.2 Main Business/Business Overview 
3.1.3 Products, Services and Solutions 
3.1.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.1.5 Recent Developments 
3.2 GlaxoSmithKline 
3.2.1 Company Profile 
3.2.2 Main Business/Business Overview 
3.2.3 Products, Services and Solutions 
3.2.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.2.5 Recent Developments 
3.3 Ranbaxy Laboratories 
3.3.1 Company Profile 
3.3.2 Main Business/Business Overview 
3.3.3 Products, Services and Solutions 
3.3.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.3.5 Recent Developments 
3.4 Ipca Laboratories Ltd 
3.4.1 Company Profile 
3.4.2 Main Business/Business Overview 
3.4.3 Products, Services and Solutions 
3.4.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.4.5 Recent Developments 
3.5 Zydus Cadila 
3.5.1 Company Profile 
3.5.2 Main Business/Business Overview 
3.5.3 Products, Services and Solutions 
3.5.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.5.5 Recent Developments 
3.6 Merck KGaA 
3.6.1 Company Profile 
3.6.2 Main Business/Business Overview 
3.6.3 Products, Services and Solutions 
3.6.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.6.5 Recent Developments 
3.7 Novartis AG 
3.7.1 Company Profile 
3.7.2 Main Business/Business Overview 
3.7.3 Products, Services and Solutions 
3.7.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.7.5 Recent Developments 
3.8 Alvizia Health Care 
3.8.1 Company Profile 
3.8.2 Main Business/Business Overview 
3.8.3 Products, Services and Solutions 
3.8.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.8.5 Recent Developments 
3.9 Bayer 
3.9.1 Company Profile 
3.9.2 Main Business/Business Overview 
3.9.3 Products, Services and Solutions 
3.9.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.9.5 Recent Developments 
3.10 Roche 
3.10.1 Company Profile 
3.10.2 Main Business/Business Overview 
3.10.3 Products, Services and Solutions 
3.10.4 Antimalarial Drug Revenue (Value) (2012-2017) 
3.10.5 Recent Developments

Continued….

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1274061

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Health Ingredients Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Health Ingredients Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022

PUNE, INDIA, October 18, 2017 /EINPresswire.com/ — Health Ingredients Market 2017

Wiseguyreports.Com adds “Health Ingredients Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database.

Report Details:

This report provides in depth study of “Health Ingredients Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Health Ingredients Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies Health Ingredients in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering 
Archer Daniels Midland Company 
Associated British Foods PLC 
Du Pont 
Kerry Group PLC 
Koninklijke Dsm N.V. 
BASF SE 
Cargill 
Ingredion Incorporated 
Arla Foods Amba 
Tate & Lyle PLC 
Lonza Group Ltd. 
Royal Frieslandcampina N.V.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2348980-global-health-ingredients-market-professional-survey-report-2017

By types, the market can be split into 
Vitamins 
Minerals 
Prebiotics 
Nutritional Lipids 
Probiotic Stater Cultures 
Other

By Application, the market can be split into 
Food 
Beverages 
Pharmaceuticals 
Animal Feed 
Personal Care

By Regions, this report covers (we can add the regions/countries as you want) 
North America 
China 
Europe 
Southeast Asia 
Japan 
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/2348980-global-health-ingredients-market-professional-survey-report-2017

Major Key Points in Table of Content:

1 Industry Overview of Health Ingredients 
1.1 Definition and Specifications of Health Ingredients 
1.1.1 Definition of Health Ingredients 
1.1.2 Specifications of Health Ingredients 
1.2 Classification of Health Ingredients 
1.2.1 Vitamins 
1.2.2 Minerals 
1.2.3 Prebiotics 
1.2.4 Nutritional Lipids 
1.2.5 Probiotic Stater Cultures 
1.2.6 Other 
1.3 Applications of Health Ingredients 
1.3.1 Food 
1.3.2 Beverages 
1.3.3 Pharmaceuticals 
1.3.4 Animal Feed 
1.3.5 Personal Care 
1.4 Market Segment by Regions 
1.4.1 North America 
1.4.2 China 
1.4.3 Europe 
1.4.4 Southeast Asia 
1.4.5 Japan 
1.4.6 India

2 Manufacturing Cost Structure Analysis of Health Ingredients 
2.1 Raw Material and Suppliers 
2.2 Manufacturing Cost Structure Analysis of Health Ingredients 
2.3 Manufacturing Process Analysis of Health Ingredients 
2.4 Industry Chain Structure of Health Ingredients

8 Major Manufacturers Analysis of Health Ingredients 
8.1 Archer Daniels Midland Company 
8.1.1 Company Profile 
8.1.2 Product Picture and Specifications 
8.1.2.1 Product A 
8.1.2.2 Product B 
8.1.3 Archer Daniels Midland Company 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.1.4 Archer Daniels Midland Company 2016 Health Ingredients Business Region Distribution Analysis 
8.2 Associated British Foods PLC 
8.2.1 Company Profile 
8.2.2 Product Picture and Specifications 
8.2.2.1 Product A 
8.2.2.2 Product B 
8.2.3 Associated British Foods PLC 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.2.4 Associated British Foods PLC 2016 Health Ingredients Business Region Distribution Analysis 
8.3 Du Pont 
8.3.1 Company Profile 
8.3.2 Product Picture and Specifications 
8.3.2.1 Product A 
8.3.2.2 Product B 
8.3.3 Du Pont 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.3.4 Du Pont 2016 Health Ingredients Business Region Distribution Analysis 
8.4 Kerry Group PLC 
8.4.1 Company Profile 
8.4.2 Product Picture and Specifications 
8.4.2.1 Product A 
8.4.2.2 Product B 
8.4.3 Kerry Group PLC 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.4.4 Kerry Group PLC 2016 Health Ingredients Business Region Distribution Analysis 
8.5 Koninklijke Dsm N.V. 
8.5.1 Company Profile 
8.5.2 Product Picture and Specifications 
8.5.2.1 Product A 
8.5.2.2 Product B 
8.5.3 Koninklijke Dsm N.V. 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.5.4 Koninklijke Dsm N.V. 2016 Health Ingredients Business Region Distribution Analysis 
8.6 BASF SE 
8.6.1 Company Profile 
8.6.2 Product Picture and Specifications 
8.6.2.1 Product A 
8.6.2.2 Product B 
8.6.3 BASF SE 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.6.4 BASF SE 2016 Health Ingredients Business Region Distribution Analysis 
8.7 Cargill 
8.7.1 Company Profile 
8.7.2 Product Picture and Specifications 
8.7.2.1 Product A 
8.7.2.2 Product B 
8.7.3 Cargill 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.7.4 Cargill 2016 Health Ingredients Business Region Distribution Analysis 
8.8 Ingredion Incorporated 
8.8.1 Company Profile 
8.8.2 Product Picture and Specifications 
8.8.2.1 Product A 
8.8.2.2 Product B 
8.8.3 Ingredion Incorporated 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.8.4 Ingredion Incorporated 2016 Health Ingredients Business Region Distribution Analysis 
8.9 Arla Foods Amba 
8.9.1 Company Profile 
8.9.2 Product Picture and Specifications 
8.9.2.1 Product A 
8.9.2.2 Product B 
8.9.3 Arla Foods Amba 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.9.4 Arla Foods Amba 2016 Health Ingredients Business Region Distribution Analysis 
8.10 Tate & Lyle PLC 
8.10.1 Company Profile 
8.10.2 Product Picture and Specifications 
8.10.2.1 Product A 
8.10.2.2 Product B 
8.10.3 Tate & Lyle PLC 2016 Health Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis 
8.10.4 Tate & Lyle PLC 2016 Health Ingredients Business Region Distribution Analysis 

Continued….

Buy now @ https://www.wiseguyreports.com/checkoutcurrency=one_user-USD&report_id=2348980

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire